Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Translational Medicine at UniSa
ISSN 2239-9747
Translational Medicine at UniSa: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; 0 articles in 2025.
Scope
Aims, scope and focus
Translational Medicine at UniSa is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Aging, Elder Care, and Social Issues, together about 24.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Dissemination of scientific and medical research is quicker and smoother in open access on-line journals and thus TranslationalMedicine has been developed as a forum for the free and open international exchange of progress in Medicine. Translational research is a set of processes aiming to bridge the gap between laboratory discoveries and clinical medicine by harnessing and integrating advances in basic and medical sciences, and converting them into novel approaches for disease prevention, diagnosis and treatment, and also to provide feedback from clinical observations to experimental basic biology research. To this aim the Journal welcomes all health-related papers concerned with the pre-clinical subjects and medical sciences as well as the studies in multiple basic science areas that include but are not limited to molecular and cell biology, genetics, pathophysiology, and epidemiology.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine11.3%
- SARS-CoV-2 and COVID-19 ResearchMedicine6.5%
- Aging, Elder Care, and Social IssuesHealth Professions6.5%
- Genetics, Aging, and Longevity in Model OrganismsBiochemistry, Genetics and Molecular Biology4.8%
- Airway Management and Intubation TechniquesMedicine4.8%
- Nosocomial Infections in ICUMedicine4.8%
- Dementia and Cognitive Impairment ResearchMedicine3.2%
- Lymphoma Diagnosis and TreatmentMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 10OpenAlex ·
- i10-index
- 11OpenAlex ·
- 2-year mean citedness
- 4.25OpenAlex ·
- Share of gold OA articles
- 66.67%LetPub ·
Volume
- Articles per year
- 17LetPub ·
Articles by year OpenAlex count · 63 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 60 |
| 2025 | 0 | 0 | 92 |
| 2024 | 24 | 24 | 87 |
| 2023 | 7 | 7 | 40 |
| 2022 | 8 | 8 | 47 |
| 2021 | 10 | 10 | 19 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 3 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- ISSN
- 2239-9747
- Official links
- Journal homepage ↗OpenAlex
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Translational Medicine at UniSa
What CAS zone is Translational Medicine at UniSa in?
In the 2025 upgraded edition of the CAS Journal Ranking, Translational Medicine at UniSa is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. Zones from different editions, and from major and minor categories, are not interchangeable.
Is Translational Medicine at UniSa open access, and what is the APC?
Translational Medicine at UniSa is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .